PABPC4 activators are compounds that stimulate the activity or boost the expression of the PABPC4 protein, formally known as Poly(A) Binding Protein Cytoplasmic 4. PABPC4 is a member of the poly(A)-binding protein family, which plays a crucial role in various post-transcriptional regulatory processes associated with mRNA metabolism. These proteins bind to the poly(A) tail of mRNA molecules, influencing mRNA stability, translation efficiency, and the initiation of protein synthesis.
The primary function of PABPC4, similar to other members of its family, is to bind to the 3' poly(A) tail of eukaryotic mRNAs. This interaction serves multiple purposes. Firstly, it facilitates the circularization of mRNA, bringing the 5' cap in close proximity to the 3' tail, which is believed to enhance translation initiation. Secondly, PABPC4 binding to the poly(A) tail can protect mRNA from exonucleolytic degradation, thereby stabilizing it. Furthermore, PABPC4 is involved in interactions with various proteins, forming dynamic complexes that regulate the translation and stability of specific mRNA subsets. PABPC4 activators, by promoting its activity or expression, can amplify these post-transcriptional regulatory processes. Delving into the mechanisms and functionalities of PABPC4 and its activators provides insight into the intricate pathways that govern mRNA metabolism in the cell. The understanding of these pathways and the role of activators in modulating them showcases the sophisticated layers of regulation that exist to ensure precise control over gene expression at the post-transcriptional level. As we uncover the nuances of PABPC4's functionality and its modulation by activators, we gain a deeper appreciation for the cellular orchestration involved in maintaining homeostasis and responding to diverse cellular cues.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid is an HDAC inhibitor that affects gene transcription, potentially leading to the upregulation of PABPC4 due to increased histone acetylation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA Methyltransferase Inhibitor that might upregulate PABPC4 due to the demethylation of its gene promoter. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor, and its action might lead to the upregulation of PABPC4 due to decreased protein degradation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is an HDAC inhibitor that may increase PABPC4 expression through increased histone acetylation, promoting gene transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine is a DNA Methyltransferase Inhibitor that could potentially upregulate PABPC4 expression by inhibiting methylation, leading to gene activation. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $100.00 $200.00 | 13 | |
Anacardic acid is a histone acetyltransferase inhibitor that could potentially elevate PABPC4 expression by influencing histone modification. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
RGFP966 is a HDAC3-specific inhibitor, and its action might result in the upregulation of PABPC4 due to specific histone deacetylase inhibition. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
Mocetinostat is an HDAC inhibitor that may promote PABPC4 transcription due to increased histone acetylation. | ||||||
PCI-24781 | 783355-60-2 | sc-364565 sc-364565A | 5 mg 50 mg | $182.00 $1330.00 | 1 | |
PCI-24781 is an HDAC inhibitor that could enhance PABPC4 expression through increased histone acetylation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 is an HDAC inhibitor that could potentially upregulate PABPC4 by promoting gene transcription through histone acetylation. | ||||||